Novel neutralizing SARS-CoV-2-specific mAbs offer detection of RBD linear epitopes

Novel neutralizing SARS-CoV-2-specific mAbs offer detection of RBD linear epitopes

Abstract Background To stop the spread of the COVID-19 disease, it is crucial to create molecular tools to investigate and diagnose COVID-19. Current efforts focus on developing specific neutralizing monoclonal antibodies (NmAbs) elicited against the receptor-binding domain (RBD). Methods In the pre...

Full description

Bibliographic Details
Main Authors: Seyed Mostafa Mostafavi Zadeh, Ali Ahmad Bayat, Hosein Shahsavarani, Feridoun Karimi-Busheri, Jafar Kiani, Roya Ghods, Zahra Madjd
Format: Article
Language:English
Published: BMC 2024-02-01
Series:Virology Journal
Subjects:
Linear epitope
Monoclonal antibody
Neutralizing antibody
RBD
SARS-CoV-2
Online Access:https://doi.org/10.1186/s12985-024-02304-2

Internet

https://doi.org/10.1186/s12985-024-02304-2

Similar Items